Today Tarsus Pharmaceuticals Inc (NASDAQ: TARS) is trading 7.25% up.

The latest price, as of 12:09:11 est, was $13.86. Tarsus has risen $0.94 in trading today.

66,315 shares exchanged hands.

As of the previous close, Tarsus has moved YTD 42.36%. The company is set to release earnings on 2022-08-03.

For technical charts, analysis, and more on Tarsus visit the company profile.

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address a number of diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 for the treatment of Demodex blepharitis. TP-03 is also being developed for the treatment of Meibomian Gland Disease.

To get more information on Tarsus Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Tarsus Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan

'Goldilocks' Stocks Will Define This Decade

What You Need To Know About Bear Markets

Is Your iPhone Already Obsolete?